|
 |

Depression is a serious medical illness affecting more than 14 million
American adults every year.
It results in a persistent state of sadness that may interfere with an
individual’s thoughts, behavior, mood, and physical health.
Symptoms may include:
- Lack of interest in or pleasure from activities typically enjoyed
- Difficulty thinking or concentrating
- Feelings of worthlessness, hopelessness, helplessness, or guilt
- Changes in sleep habits and energy levels
- Significant weight gain or weight loss
While the exact cause of depression is not known, the leading scientific
theory is that depression is caused by an imbalance of the brain’s
neurotransmitters.
Neurotransmitters are chemical messengers that send
signals between brain cells. Depression is most often treated with
antidepressant medications. It is believed that antidepressant medications
work by increasing the levels of these neurotransmitters.
The new way back from depression and its treatment side effects
Although antidepressants can be effective for many patients, they do not
work for everybody. Additionally, since antidepressant medications are
typically taken by mouth, they circulate in the bloodstream throughout
the body, often resulting in unwanted side effects such as weight gain,
sexual problems, upset stomach, sleepiness, and dry mouth.
More than 4 million patients do not receive adequate benefit from
antidepressants and/or cannot tolerate the side effects caused by them.
For these patients, NeuroStar TMS Therapy offers the new way back from
depression and its treatment side effects.
View the NeuroStar TMS Therapy system.
|
 |
 |
|
Refer a Patient for Treatment
|
NeuroStar TMS Therapy may be right for your patients suffering from major depression. Refer them here.
Find a Provider
|
 |
 |
|
Become a NeuroStar TMS Therapy Provider
|
Provide your patients the new way back from depression with NeuroStar TMS Therapy®.
Contact us to find out how you can bring NeuroStar into your workplace.
Contact Us
|
 |
|
*
NeuroStar TMS Therapy® is indicated for the treatment of Major Depressive
Disorder in adult patients who have failed to achieve satisfactory improvement from
one prior antidepressant medication at or above the minimal effective dose and duration
in the current episode.
|